Marcyrl Pharmaceutical Industries
AMR Khaled is an experienced professional in the pharmaceutical industry, currently serving as the R&D Formulation Head at Marcyrl Pharmaceutical Industries since March 2024. Previously, AMR worked as the New Products and Formulation Head at Gypto Pharma from January 2022 to February 2024, overseeing R&D technical operations and product feasibility studies. AMR has also held roles such as R&D Formulation Head at Nawah Scientific and R&D Formulation Section Head at Amoun Pharmaceutical Industries, where responsibilities included managing formulation labs and leading technology transfers. With a strong educational background, AMR holds a Master's degree in Industrial Pharmacy from Ain Shams University and is currently pursuing an MBA from the Brooklyn Institute.
This person is not in any offices
Marcyrl Pharmaceutical Industries
Marcyrl Group, One of the Leading Global Pharmaceutical Companies, EU GMP-Certified Egyptian manufacturers provide innovative diversified specialty care treatments in different therapeutic areas, with a strong presence covering Africa and GCC, CIS, and LATAM to deliver cost-effective critical solutions to healthcare practitioners and their patients across the continents. At Marcyrl, we are working to transform the way specialty treatments are made accessible worldwide, ensuring that specialty care treatments are of high quality and available to those who need them the most, has secured investment from Development Partners International (DPI) and Amethis.